KMID : 0361420070310060750
|
|
Journal of Korean Academy of Rehabilitation Medicine 2007 Volume.31 No. 6 p.750 ~ p.755
|
|
Comparison on Treatment Effects of Pharmaceutic Agents for Trigger Point Injection.
|
|
Han Soo-Jeong
Lee Kyung-Hwan
|
|
Abstract
|
|
|
OBJECTIVE: To compare the effect of pharmaceutic agents which were used in trigger point injection and to establish a relationship between ultrasonographic change in injected muscle and post-injection soreness by a double blinded study.
METHOD: Twenty-seven patients who were diagnosed as myofascial pain syndrome with their trigger point in upper trapezius muscle were recruited. They were assigned to four groups by age and sex: lidocaine injection (n=8), normal saline injection (n=6), 20%dextrose injection (n=6), and BTX-A injection (n=7). One physiatrist palpated a trigger point at upper trapezius muscle and injected blinded agents with same volume (1 ml). Ultrasonography for injected muscle was done by 2 weeks after injection. Visual analog scale was evaluated up to twenty three weeks.
RESULTS: Mean score of visual analog scale was decreased in all groups. Among the four agents, 0.5% lidocaine and BTX-A showed significant decrement in visual analog scale (p<0.05). Ultrasonographic depth of muscle was increased in BTX-A and 20% dextrose injected group at the end of injection (p<0.05). There were no significant different treatment effect in four pharmaceutic agents.
CONCLUSION: In all four groups, trigger point injection showed therapeutic effect for myofascial pain syndrome. Among the four agents, 0.5% lidocaine and BTX-A could reduce pain significantly up to twenty three weeks. Mechanical pressure on muscle fiber was thought to be one of the causes of post-injection soreness.
|
|
KEYWORD
|
|
Myofascial pain syndrome, Trigger point, Botulinum toxin type A, Lidocaine, Ultrasonography
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|